COMPUGEN LTD
CGENBiological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001119774
Revenue FY2025
$73.0M
Net Income
$35.0M
EPS (Basic)
$0.38
Net Margin
48.6%
ROE
34.4%
Total Equity
$103.0M
Shares Out
95M
COMPUGEN LTD — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 20-F (foreign private issuer annual report) via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Matrix Asset Advisors
David Katz
$0.2M
0.0%
—
ARK Investment Management
ARK Investment Management
$1.7M
0.0%
(25.1%)
Insider Transactions
Reading stored insider transactions…